Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod
Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod
批准号:
10927554
负责人:
CHINTHALAPALLY RAO
金额:
$114.04万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-11 至 2026-09-10
关键词:
American Association of Cancer ResearchAnimal Cancer ModelAnimalsApoptosisBiological MarkersBlood Chemical AnalysisBody WaterBody WeightCell ProliferationChemopreventive AgentColonColon CarcinomaColonic PolypsColonoscopyColorectal NeoplasmsCommunitiesConsultationsContractorContractsDevelopmentDinoprostoneDoseFamilial Adenomatous Polyposis SyndromeFundingGovernmentHistologyHuman ResourcesInbred F344 RatsIncidenceInflammationKidneyLiteratureLiverLungMalignant NeoplasmsMeasurementMeasuresMissionModelingMonitorNotificationOralOral AdministrationOrganPathway interactionsPlasmaPolypsPreclinical Drug DevelopmentPrincipal InvestigatorProgram DevelopmentProgress ReportsRattusReportingResearchSafetySamplingScheduleSignal PathwaySlideSmall Intestinal PolypSpleenSulindacTechnologyTestingToxic effectToxicologyTravelTumor BurdenWFDC2 geneWater consumptionWorkbasecancer preventioncarcinogenesisclinical translationcolorectal cancer preventionefficacy evaluationefficacy studyimmunoregulationinnovationmeetingsneoplastic cellnovelposterspreclinical efficacypredictive markerpreventive interventionprogramsresearch and developmentsymposiumtreatment durationtumorvaccinology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of this Task Order is to evaluate the efficacy and preliminary safety of TPST-1495 for the prevention of Colorectal Cancer (CRC) associated with Familial Adenomatous Polyposis (FAP) in PIRC rat model. The Government will provide TPST-1495 to the Contractor for use under the effort described in the Statement of Work.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
-
批准号:10677989
-
项目类别:
-
资助金额:$104.61万
-
财政年份:2022
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT
-
批准号:10705393
-
项目类别:
-
资助金额:$98.23万
-
财政年份:2022
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERSTASK ORDER TITLE: PREVENTING FAP-CRC USING
-
批准号:10652736
-
项目类别:
-
资助金额:$14.33万
-
财政年份:2022
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM - A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
-
批准号:10503245
-
项目类别:
-
资助金额:$48.25万
-
财政年份:2021
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM - A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
-
批准号:10678625
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2021
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
PREVENT EFFICACY POOL: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
-
批准号:10411703
-
项目类别:
-
资助金额:$91.15万
-
财政年份:2021
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
TASK ORDER TITLE: PREVENTING COLORECTAL CANCER USING TRAIL-INDUCING ONC201 ALONE OR IN COMBINATION WITH NSAID
-
批准号:10269144
-
项目类别:
-
资助金额:$87.95万
-
财政年份:2020
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
CHEMOPREVENTION WITH AEROSOLIZED LET-7 MICRORNA IN MOUSE MODELS OF NON-SMALL CELL LUNG CANCER (ADENOCARCINOMA AND SQUAMOUS CELL CARCINOMA)
-
批准号:10020543
-
项目类别:
-
资助金额:$84.94万
-
财政年份:2019
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
IGF::OT::IGF PROSTATE CANCER PREVENTION BY ASPIRIN AND/OR OTHER NSAIDS TORFP 2016-E03HHSN2612015000381PERIOD OF PERFORMANCE: 07/07/2016 - 03/06/2019
-
批准号:9360885
-
项目类别:
-
资助金额:$62.51万
-
财政年份:2016
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
IGF::OT::IGF PREVENT EFFICACY: OPTIMIZATION OF GEM MODELS FOR HIGH-RISK COHORTS OF HUMAN PANCREATIC CYSTADENOMAS, IPMNS, AND PANINS PROGRESSION TO PDAC.
-
批准号:9152469
-
项目类别:
-
资助金额:$59.94万
-
财政年份:2015
-
负责人:CHINTHALAPALLY RAO
-
依托单位:
HHSN261201200020I/HHSN26100007Preclinical In Vitro and In Vivo Development Assays for Cancer Preventative Reagent. Project Title: Chemoprevention by Aerosolized Bexarotene in Mouse Models of All T
-
批准号:8945362
-
项目类别:
-
资助金额:$60.71万
-
财政年份:2014
-
负责人:CHINTHALAPALLY RAO
-
依托单位:--
Molecular Heterogeneity of Inflammation and Growth Factor Pathways in Sporadic and Syndromic Colon Cancers: Implications for Prevention and Therapeutic TrialsPOP: 09/15/2014-09/14/2015
-
批准号:8944482
-
项目类别:
-
资助金额:$48.2万
-
财政年份:2014
-
负责人:CHINTHALAPALLY RAO
-
依托单位:--
HHSN2612012000131/HHSN26100010Base Contract Title: Preclinical Efficacy and Intermediate Endpoint Biomarkers. Task Order Title: Preclinical Studies to Evaluate the Combination of Metformin and As
-
批准号:8947463
-
项目类别:
-
资助金额:$53.09万
-
财政年份:2014
-
负责人:CHINTHALAPALLY RAO
-
依托单位:--
Multi-Antigen Vaccine for Lung Cancer PreventionPOP: 09/18/2014-09/17/2016
-
批准号:8941097
-
项目类别:
-
资助金额:$88.45万
-
财政年份:2014
-
负责人:CHINTHALAPALLY RAO
-
依托单位:--
HHSN2612012000201/HHSN26100006 Title: Preclinical In Vitro And In Vivo Screening Assays For Cancer Preventative Reagent Development, Project: Targeting CCK2R for Pancreatic Cancer Prevention
-
批准号:8944735
-
项目类别:
-
资助金额:$47.46万
-
财政年份:2014
-
负责人:CHINTHALAPALLY RAO
-
依托单位:--